Pathogenesis of joint destruction in rheumatoid arthritis

Archivum Immunologiae et Therapiae Experimentalis

Volumn 59, Issue 2, 2011, Pages 89-95

  Shiozawa, Shunichi ^a,b,c,d   Tsumiyama, Ken ^b   Yoshida, Kohsuke ^b   Hashiramoto, Akira ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY HOSPITAL   (Japan)

^c KOBE UNIVERSITY   (Japan)

^d Investigator of the Center of Excellence (COE)   (Japan)

Author keywords

c Fos; c Fos AP 1; IL 1beta; Joint destruction; Rheumatoid arthritis

Indexed keywords

INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN C FOS; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR;

ANTIGEN SPECIFICITY; BINDING SITE; BONE DEFECT; BONE MATRIX; CARTILAGE DEGENERATION; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ACTIVE SITE; EXTRACELLULAR MATRIX; GENETIC TRANSCRIPTION; HUMAN; IMMUNE RESPONSE; JOINT DESTRUCTION; MESENCHYME CELL; MITOSIS; MOLECULAR INTERACTION; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PATHOGENESIS; PROTEIN PHOSPHORYLATION; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM; T LYMPHOCYTE; TRANSACTIVATION; UPREGULATION;

ANIMALS; ARTHRITIS, RHEUMATOID; HUMANS; INFLAMMATION MEDIATORS; JOINTS; MATRIX METALLOPROTEINASES; MESODERM; OSTEOCLASTS; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE;

EID: 79952538935     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-011-0116-3     Document Type: Review

References (99)

1. D Ahrens AE Koch RM Pope, et al. 1996 Expression of matrix metalloproteinase 9 (96-kD gelatinase B) in human rheumatoid arthritis Arthritis Rheum 39 1576 1587 8814070 10.1002/art.1780390919 1:STN:280: DyaK28vgvFSrtQ%3D%3D (Pubitemid 26314993)
2. Y Aikawa K Morimoto T Yamamoto, et al. 2008 Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1 Nat Biotechnol 26 817 823 18587386 10.1038/nbt1412 1:CAS:528:DC%2BD1cXot1ent7Y%3D (Pubitemid 351961451)
3. P Angel M Karin 1991 The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation Biochim Biophys Acta 1072 129 157 1751545 1:CAS:528:DyaK38XjvVOlug%3D%3D (Pubitemid 121007534)
4. P Angel M Imagawa R Chiu, et al. 1987 Phorbol ester inducible genes contain a common cis element recognized by a TPA-modulated transacting factor Cell 49 729 739 3034432 10.1016/0092-8674(87)90611-8 1:CAS:528: DyaL1cXltVCntA%3D%3D (Pubitemid 18094763)
5. M Asagiri T Hirai T Kunigami, et al. 2008 Cathepsin K-dependent Toll-like receptor 9 signaling revealed in experimental arthritis Science 319 624 627 18239127 10.1126/science.1150110 1:CAS:528:DC%2BD1cXht1Knt7s%3D (Pubitemid 351197065)
6. H Asahara K Fujisawa T Kobata, et al. 1997 Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium Arthritis Rheum 40 912 918 9153554 10.1002/art.1780400520 1:CAS:528: DyaK2sXjsV2hsLk%3D (Pubitemid 27200009)
7. NA Athanasou J Quinn A Heryet, et al. 1988 The immunohistology of synovial lining cells in normal and inflamed synovium J Pathol 155 133 142 2969046 10.1002/path.1711550210 1:STN:280:DyaL1c3nsVKlsw%3D%3D
8. P Barland AB Novikoff D Hamerman 1962 Electron microscopy of the human synovial membrane J Cell Biol 14 207 220 13865038 10.1083/jcb.14.2.207 1:STN:280:DyaF38%2Fgs1ejtg%3D%3D
9. S Beggs MW Salter 2008 Taking two cuts at pain Nat Med 14 243 244 18323841 10.1038/nm0308-243 1:CAS:528:DC%2BD1cXivFOrtbo%3D (Pubitemid 351347901)
10. J Bondeson B Foxwell F Brennan, et al. 1999 Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators Proc Natl Acad Sci USA 96 5668 5673 10318942 10.1073/pnas.96.10.5668 1:CAS:528:DyaK1MXjtFCntLs%3D (Pubitemid 29234676)
11. PS Burrage KS Mix CE Brinckerhoff 2006 Matrix metalloproteinase: role in arthritis Front Biosci 11 529 543 16146751 10.2741/1817 1:CAS:528: DC%2BD2MXhtlSrurrE
12. S Chakraborti M Mandal S Das, et al. 2003 Regulation of matrix metalloproteinases: an overview Mol Cell Biochem 253 269 285 14619979 10.1023/A:1026028303196 1:CAS:528:DC%2BD3sXnslSgsbc%3D (Pubitemid 37321735)
13. IC Chikanza P Roux-Lombrad JM Dayer, et al. 1995 Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Pathogenetic implications Arthritis Rheum 38 64 648
14. Dayer JM (2003) The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis. Rheumatology 42(Suppl. 2):ii3-ii10
15. JM Dayer B Beutler A Cerami 1985 Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts J Exp Med 162 2163 2168 2999289 10.1084/jem.162.6.2163 1:CAS:528:DyaL28Xmslanug%3D%3D (Pubitemid 16149701)
16. Delaisse J, Vaes G (1992) Mechanism of mineral solubilisation and matrix degradation in osteoclastic bone resorption. In: Rifkin BR, Gay CV (eds) Biology and physiology of the osteoclast. CRC Press, Boca Raton
17. JA Eastgate JA Symons NC Wood, et al. 1988 Correlation of plasma interleukin-1 levels with disease activity in rheumatoid arthritis Lancet 2 706 708 2901567 10.1016/S0140-6736(88)90185-7 1:STN:280:DyaL1czjsVSmsw%3D%3D
18. Fassbender HG (1975) Pathology of rheumatic diseases. Springer-Verlag, Berlin
19. HG Fassbender 1984 Is pannus a residue of inflammation? Arthritis Rheum 27 956 957 6466399 10.1002/art.1780270819 1:STN:280:DyaL2c3otVahsA%3D%3D
20. P Garnero E Thompson T Woodworth, et al. 2010 Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone Arthritis Rheum 62 33 43 20039425 10.1002/art.25053 1:CAS:528:DC%2BC3cXhtFGnurnI
21. EM Gravallese SR Goldring 2000 Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritis Arthritis Rheum 43 2143 2151 11037873 10.1002/1529-0131(200010)43:10<2143::AID-ANR1>3.0.CO;2-S 1:CAS:528:DC%2BD3cXnslWjsrs%3D
22. A Gutman B Wasylyk 1990 The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites EMBO J 9 2241 2246 2162765 1:CAS:528:DyaK3cXkslagt7Y%3D
23. RM Hembry MR Bagga JJ Reynolds, et al. 1995 Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2 in synovia from patients with osteo- and rheumatoid arthritis Ann Rheum Dis 54 25 32 7880117 10.1136/ard.54.1.25 1:STN:280:DyaK2M7osFygug%3D%3D
24. B Henderson ER Pettipher 1989 Arthritogenic actions of recombinant IL-1 and TNF in the rabbit: evidence for synergistic interactions between cytokines in vivo Clin Exp Immunol 75 306 310 2784740 1:CAS:528:DyaL1MXhslWmtL8%3D (Pubitemid 19074265)
25. J Hess D Porte C Munz, et al. 2001 AP-1 and Cbfa/Runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element J Biol Chem 276 20029 20038 11274169 10.1074/jbc.M010601200 1:CAS:528:DC%2BD3MXktlKnsrc%3D
26. R Horai S Saijo H Tanioka, et al. 2000 Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in IL-1 receptor antagonist-deficient mice J Exp Med 191 313 320 10637275 10.1084/jem.191.2.313 1:CAS:528:DC%2BD3cXntFemsw%3D%3D (Pubitemid 30060920)
27. Y Jiang HK Genant I Watt, et al. 2000 A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores Arthritis Rheum 43 1001 1009 10817552 10.1002/1529-0131(200005)43:5<1001::AID- ANR7>3.0.CO;2-P 1:CAS:528:DC%2BD3cXjvVeitbg%3D (Pubitemid 30368176)
28. MJ Jimenez M Balbin JM Lopez, et al. 1999 Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation Mol Cell Biol 19 4431 4442 10330183 1:CAS:528:DyaK1MXjt1yis7w%3D (Pubitemid 29242017)
29. LA Joosten 2010 Excessive interleukin-1 signaling determines the development of Th1 and Th17 responses in chronic inflammation Arthritis Rheum 62 320 322 20112403 10.1002/art.27242 1:CAS:528:DC%2BC3cXhtFGnu77I
30. LA Joosten MM Helsen T Saxne, et al. 1999 IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint destruction J Immunol 163 5049 5055 10528210 1:CAS:528:DyaK1MXmvFajtbY%3D (Pubitemid 29501273)
31. P Kahle JG Saal K Schaudt, et al. 1992 Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial fluid Ann Rheum Dis 51 731 734 1616355 10.1136/ard.51.6.731 1:STN:280:DyaK38zhtlSquw%3D%3D
32. M Karin Z Liu E Zandi 1997 AP-1 function and regulation Curr Opin Cell Biol 9 240 246 9069263 10.1016/S0955-0674(97)80068-3 1:CAS:528: DyaK2sXisVWlsL0%3D (Pubitemid 27135992)
33. H Kawasaki K Komai Z Ouyang, et al. 2001 c-Fos/activator protein-1 transactivates wee1 kinase at G1/S to inhibit premature mitosis in antigen-specific Th1 cells EMBO J 20 4618 4627 11500387 10.1093/emboj/20.16.4618 1:CAS:528:DC%2BD3MXmsVehurs%3D (Pubitemid 32772054)
34. H Kawasaki K Komai M Nakamura, et al. 2003 Human wee1 kinase is directly transactivated by and increased in association with c-Fos/AP-1: rheumatoid synovial cells overexpressing these genes go into aberrant mitosis Oncogene 22 6839 6844 14534529 10.1038/sj.onc.1206903 1:CAS:528:DC%2BD3sXnvFSgtro%3D (Pubitemid 37386682)
35. Y Kawasaki ZZ Xu X Wang, et al. 2008 Distinct roles of matrix metalloproteinases in the early- and late-phase development of neuropathic pain Nat Med 14 331 336 18264108 10.1038/nm1723 1:CAS:528:DC%2BD1cXivFOrt7k%3D (Pubitemid 351347915)
36. H Kimura H Tateishi M Ziff 1977 Surface ultrastructure of rheumatoid articular cartilage Arthritis Rheum 20 1085 1098 869956 10.1002/art.1780200508 1:STN:280:DyaE2s3gtFKitg%3D%3D
37. L Klareskog U Forsum D Kabelitz, et al. 1982 Immune functions of human synovial cells: phenotypic and T cell regulatory properties of macrophage-like cells that express HLA-DR Arthritis Rheum 25 488 501 6211176 10.1002/art.1780250502 1:STN:280:DyaL383gs1aisw%3D%3D (Pubitemid 12115844)
38. K Kobayashi N Takahashi E Jimi, et al. 2000 Tumor necrosis factor stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction J Exp Med 191 275 286 10637272 10.1084/jem.191.2.275 1:CAS:528:DC%2BD3cXntFenug%3D%3D (Pubitemid 30060917)
39. AE Koch SL Kunkel SW Chensue, et al. 1992 Expression of interleukin-1 and interleukin-1 receptor antagonist by human rheumatoid synovial tissue macrophages Clin Immunol Immunopathol 65 23 29 1395121 10.1016/0090-1229(92) 90243-H 1:CAS:528:DyaK3sXitVyjuw%3D%3D
40. T Koga M Inui K Inoue, et al. 2004 Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis Nature 428 758 763 15085135 10.1038/nature02444 1:CAS:528:DC%2BD2cXjtV2mt78%3D (Pubitemid 38508286)
41. K Koga G Takaesu R Yoshida, et al. 2009 Cyclic adenosine monophosphate suppresses the transcription of proinflammatory cytokines via the phosphorylated c-Fos protein Immunity 30 372 383 19285436 10.1016/j.immuni.2008.12.021 1:CAS:528:DC%2BD1MXltFSmt7w%3D
42. Y Kuroki S Shiozawa T Sugimoto, et al. 1992 Constitutive expression of c-fos gene inhibits type 1 collagen synthesis in transfected osteoblasts Biochem Biophys Res Commun 182 1389 1394 1540182 10.1016/0006-291X(92)91887-V 1:CAS:528:DyaK38XhslWjsL8%3D
43. Y Kuroki S Shiozawa R Yoshihara, et al. 1993 The contribution of human c-fos DNA to cultured synovial cells: a transfection study J Rheumatol 20 422 428 8478846 1:CAS:528:DyaK3sXks12jsL8%3D (Pubitemid 23102462)
44. E Lindhout M van Eijk M van Pel, et al. 1999 Fibroblast-like synoviocytes from rheumatoid arthritis patients have intrinsic properties of follicular dendritic cells J Immunol 162 5949 5956 10229832 1:CAS:528:DyaK1MXjt12ltbg%3D (Pubitemid 29314950)
45. LS Lohmander PJ Neame JD Sandy 1993 The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis Arthritis Rheum 36 1214 1222 8216415 10.1002/art.1780360906 1:CAS:528: DyaK2cXitFCns78%3D (Pubitemid 23303112)
46. JA Mengshol MP Vincenti CE Brinckerhoff 2001 IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocyotic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways Nucleic Acids Res 29 4361 4372 11691923 10.1093/nar/29.21.4361 1:CAS:528:DC%2BD3MXovFals7c%3D (Pubitemid 33064776)
47. JM Milner A Patel AD Rowan 2008 Emerging roles of serine proteinases in tissue turnover in arthritis Arthritis Rheum 58 3644 3656 19035508 10.1002/art.24046 1:CAS:528:DC%2BD1MXmt1yntA%3D%3D
48. A Miyauchi Y Kuroki M Fukase, et al. 1994 Persistent expression of proto-oncogene c-fos stimulates osteoclast differentiation Biochem Biophys Res Commun 205 1547 1555 7811235 10.1006/bbrc.1994.2843 1:CAS:528:DyaK2MXivV2rt7g%3D
49. JS Mudgett NI Hutchinson NA Chartrain, et al. 1998 Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction Arthritis Rheum 41 110 121 9433876 10.1002/1529-0131(199801)41: 1<110::AID-ART14>3.0.CO;2-G 1:CAS:528:DyaK1cXmslyktA%3D%3D (Pubitemid 28041929)
50. G Murphy F Willenbrock 1995 Tissue inhibitors of matrix metalloendopeptidases Methods Enzymol 248 496 510 7674941 10.1016/0076-6879(95) 48032-3 1:CAS:528:DyaK2MXptVShs7c%3D
51. Y Okada 2000 Matrix-degrading metalloproteinases and their roles in joint destruction Mod Rheumatol 10 121 128 10.1007/s101650070018
52. Y Okada N Takeuchi K Tomita, et al. 1989 Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis Ann Rheum Dis 48 645 653 2675782 10.1136/ard.48.8.645 1:STN:280:DyaL1MzptFKgtQ%3D%3D (Pubitemid 19201961)
53. Y Okada Y Gonoji I Nakanishi, et al. 1990 Immunohitochemical demonstration of collagenase and tissue inhibitor of metalloproteinases (TIMP) in synovial lining cells of rheumatoid synovium Virchows Arch B Cell Pathol Incl Pathol 59 305 312 10.1007/BF02899418 1:CAS:528:DyaK3MXltFais7k%3D (Pubitemid 20369611)
54. Y Okada K Naka K Kawamura, et al. 1995 Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in Osteoclasts: implications for bone resorption Lab Invest 72 311 322 7898050 1:CAS:528:DyaK2MXls1Clurw%3D
55. T Pap Y Shigeyama S Kuchen, et al. 2000 Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis Arthritis Rheum 43 1226 1232 10857781 10.1002/1529-0131(200006)43:6<1226::AID- ANR5>3.0.CO;2-4 1:CAS:528:DC%2BD3cXkvFWnur0%3D (Pubitemid 30416307)
56. Pap T, Gay S, Schett G (2002) Matrix metalloproteinases. In: Smolen JS, Lipsky PE (eds) Biological therapies in rheumatology. Taylor & Francis Ltd, London
57. S Porter IM Clark L Kevorkian, et al. 2004 The ADAMTS metalloproteinases Biochem J 386 Pt 1 15 27
58. LW Poulter O Duke S Hobbs, et al. 1982 Histochemical discrimination of HLA-DR positive cell populations in the normal and arthritic synovial lining Clin Exp Immunol 48 381 388 6213328 1:STN:280:DyaL383mtVSisw%3D%3D (Pubitemid 12102057)
59. L Probert D Plows G Kontogeorgos, et al. 1995 The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice Eur J Immunol 25 1794 1797 7615010 10.1002/eji.1830250647 1:CAS:528:DyaK2MXms1KlsLY%3D
60. A Ray BS Bal BK Ray 2005 Transcriptional induction of matrix metalloproteinase-9 in the chondrocyte and synoviocyte cells is regulated via a novel mechanism: evidence for functional cooperation between serum amyloid A-activating factor-1 and AP-1 J Immunol 175 4039 4048 16148153 1:CAS:528:DC%2BD2MXpslCltrw%3D (Pubitemid 41292067)
61. K Redlich S Hayer R Ricci, et al. 2002 Osteoclasts are essential for TNF-mediated joint destruction J Clin Invest 110 1419 1427 12438440 1:CAS:528:DC%2BD38XovFOnu7s%3D (Pubitemid 35396913)
62. N Reunanan SP Li M Ahonen, et al. 2002 Activation of p38 alpha MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization J Biol Chem 277 32360 32368 10.1074/jbc.M204296200 (Pubitemid 34969054)
63. M Rooney JA Symons GW Duff 1990 Interleukin-1 beta in synovial fluid is related to local disease activity in rheumatoid arthritis Rheumatol Int 10 217 219 2075374 10.1007/BF02274836 1:STN:280:DyaK3M7msVOjsw%3D%3D
64. G Schett C Stach J Zwerina, et al. 2008 How antirheumatic drugs protect joints from damage in rheumatoid arthritis Arthritis Rheum 58 2936 2948 18821703 10.1002/art.23951 1:CAS:528:DC%2BD1cXht12rur%2FI
65. A Schonthal P Herrlich HJ Rahmsdorf, et al. 1988 Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters Cell 54 325 334 2840203 10.1016/0092-8674(88)90195-X 1:STN:280:DyaL1c3ot1Gnsg%3D%3D
66. HR Schumacher 1973 Fate of particular material arriving at the synovium via the circulation. An ultrastructural study Ann Rheum Dis 32 212 218 4715539 10.1136/ard.32.3.212 1:STN:280:DyaE3s3gvFynsw%3D%3D
67. DL Scott GH Kingsley 2006 Tumor necrosis factor inhibitors for rheumatoid arthritis N Engl J Med 355 704 712 16914706 10.1056/NEJMct055183 1:CAS:528:DC%2BD28Xot12ltro%3D
68. S Shimizu S Shiozawa K Shiozawa, et al. 1985 Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis Arthritis Rheum 28 25 31 3966938 10.1002/art.1780280105 1:STN:280:DyaL2M%2FpslWhsA%3D%3D (Pubitemid 15193018)
69. S Shimizu S Shiozawa K Shiozawa, et al. 1988 The restoration of proliferation and differentiation of peripheral blood mononuclear non-adherent cells into immunoglobulin-secreting cells by autologous synovial adherent cells from patients with rheumatoid arthritis Virchows Arch B Cell Pathol Incl Mol Pathol 54 350 356 10.1007/BF02899233 (Pubitemid 18090469)
70. K Shimizu H Kawasaki T Morisawa, et al. 2000 Spontaneous and cytokine regulated c-fos gene expression in rheumatoid synovial cells Ann Rheum Dis 59 636 640 10913062 10.1136/ard.59.8.636 1:CAS:528:DC%2BD3cXmtVCitbk%3D (Pubitemid 30617090)
71. M Shinohara T Koga K Okamoto, et al. 2008 Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals Cell 132 794 806 18329366 10.1016/j.cell.2007.12.037 1:CAS:528:DC%2BD1cXjs1aitrY%3D (Pubitemid 351312796)
72. S Shiozawa Y Kuroki 1994 Osteoporosis in rheumatoid arthritis: a molecular biological aspect of connective tissue gene activation Tohoku J Exp Med 173 189 198 7809909 10.1620/tjem.173.189 1:STN:280:DyaK2M7gvVylsg%3D%3D
73. S Shiozawa T Tokuhisa 1992 Contribution of synovial mesenchymal cells to the pathogenesis of rheumatoid arthritis Semin Arthritis Rheum 21 267 273 1570520 10.1016/0049-0172(92)90058-L 1:STN:280:DyaK383jslOjtA%3D%3D
74. S Shiozawa K Tsumiyama 2009 Pathogenesis of rheumatoid arthritis and c-Fos/AP-1 Cell Cycle 8 1539 1543 19395871 10.4161/cc.8.10.8411 1:CAS:528:DC%2BD1MXptVWqtbg%3D
75. S Shiozawa K Shiozawa T Fujita 1983 Morphologic observation in the early phase of the cartilage-pannus junction: light and electron microscopic studies of active cellular pannus Arthritis Rheum 26 472 478 6838672 10.1002/art.1780260404 1:STN:280:DyaL3s7nvVCkug%3D%3D (Pubitemid 13120235)
76. S Shiozawa K Shiozawa T Fujita 1983 Presence of HLA-DR antigen on synovial type A and B cells: an immunoelectron microscopic study in rheumatoid arthritis, osteoarthritis and normal traumatic joints Immunology 50 587 594 6581119 1:STN:280:DyaL2c%2Fos1Ghsw%3D%3D (Pubitemid 14246902)
77. S Shiozawa Y Tanaka T Fujita, et al. 1992 Destructive arthritis without lymphocyte infiltration in H2-c-fos transgenic mice J Immunol 148 3100 3104 1578135 1:CAS:528:DyaK38Xkt1Cmu7c%3D
78. S Shiozawa S Shimizu K Tanaka, et al. 1997 Studies on the contribution of c-fos/AP-1 to arthritic joint destruction J Clin Invest 99 1210 1216 9077528 10.1172/JCI119277 1:CAS:528:DyaK2sXhvFyit7k%3D (Pubitemid 27142756)
79. K Sirum-Connolly C Brinckerhoff 1991 Interleukin-1 or phorbol induction of the stromelysin promoter requires an element that cooperates with AP-1 Nucleic Acids Res 19 335 341 1901643 10.1093/nar/19.2.335 1:CAS:528: DyaK3MXhtlOitr8%3D (Pubitemid 21896978)
80. Y Sun L Wenger CE Brinckerhoff, et al. 2002 Basic calcium phosphate crystals induce matrix metalloproteinase-1 through the Ras/mitogen-activated protein kinase/c-Fos/AP-1 metalloproteinase 1 pathway J Biol Chem 277 1544 1552 11682465 10.1074/jbc.M100567200 1:CAS:528:DC%2BD38XnvFyjuw%3D%3D (Pubitemid 34968912)
81. H Takayanagi 2007 Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems Nat Rev Immunol 7 292 304 17380158 10.1038/nri2062 1:CAS:528:DC%2BD2sXjtlyhurc%3D (Pubitemid 46480961)
82. SL Teitelbaum 2004 RANKing c-Jun in osteoclast development J Clin Invest 114 463 465 15314680 1:CAS:528:DC%2BD2cXmvVemu7o%3D (Pubitemid 39572093)
83. LE Theill WJ Boyle JM Penninger 2002 RANK-L and RANK: T cells, bone loss, and mammalian evolution Annu Rev Immunol 20 795 823 11861618 10.1146/annurev.immunol.20.100301.064753 1:CAS:528:DC%2BD38XjtlWgtbo%3D (Pubitemid 34293440)
84. S Thornton LE Duwel GP Boivin, et al. 1999 Association of the course of collagen-induced arthritis with distinct patterns of cytokine and chemokine messenger RNA expression Arthritis Rheum 42 1109 1118 10366103 10.1002/1529-0131(199906)42:6<1109::AID-ANR7>3.0.CO;2-7 1:CAS:528:DyaK1MXktVegt7o%3D (Pubitemid 29268947)
85. ML Tiku M Theodorescu JL Skosey 1985 Immunobiological function of normal rabbit synovial cells Cell Immunol 91 415 424 3158395 10.1016/0008-8749(85) 90239-4 1:STN:280:DyaL2M3gtFOjtA%3D%3D (Pubitemid 15087180)
86. TC Tolboom AH n Mil RG Nelissen, et al. 2005 Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis Arthritis Rheum 52 1999 2002 15986342 10.1002/art.21118 (Pubitemid 40994321)
87. A Trabandt WK Aicher RE Gay, et al. 1992 Spontaneous expression of immediately-early response genes c-fos and egr-1 in collagenase-producing rheumatoid synovial fibroblasts Rheumatol Int 12 53 59 1411083 10.1007/BF00300977 1:CAS:528:DyaK38Xlt12htLY%3D
88. CN Tran MJ Davis LA Tesmer, et al. 2007 Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes Arthritis Rheum 56 1497 1506 17469112 10.1002/art.22573 1:CAS:528:DC%2BD2sXmsFart7k%3D (Pubitemid 46764078)
89. AA van de Loo WB van den Berg 1990 Effects of murine recombinant IL-1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation Ann Rheum Dis 49 238 245 2339905 10.1136/ard.49.4.238
90. WB van den Berg 2001 Anti-cytokine therapy in chronic destructive arthritis Arthritis Res 3 18 26 11178124 10.1186/ar136 (Pubitemid 32223802)
91. WB van den Berg 2002 Lessons from animal models of arthritis Curr Rheumatol Rep 4 232 239 12010608 10.1007/s11926-002-0070-5
92. PE van den Steen B Dubois I Nelissen, et al. 2002 Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9) Crit Rev Biochem Mol Biol 37 375 536 12540195 10.1080/10409230290771546 (Pubitemid 36071972)
93. MP Vincenti CI Coon CE Brinckerhoff 1998 Nuclear factor kappaB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1 beta-stimulated synovial fibroblasts Arthritis Rheum 41 1987 1994 9811054 10.1002/1529-0131(199811)41:11<1987::AID-ART14>3.0.CO;2-8 1:CAS:528:DyaK1cXnsFKgu7Y%3D (Pubitemid 28506689)
94. MC Walsh N Kim Y Kadono, et al. 2006 Osteoimmunology: interplay between the immune system and bone metabolism Annu Rev Immunol 24 33 63 16551243 10.1146/annurev.immunol.24.021605.090646 1:CAS:528:DC%2BD28XkvFSqt74%3D
95. AJ Whitmarsh P Shore AD Sharrocks, et al. 1995 Integration of MAP kinase signal transduction pathways at the serum response element Science 269 403 407 7618106 10.1126/science.7618106 1:CAS:528:DyaK2MXntVyitb0%3D
96. H Will SJ Atkinson GS Butler, et al. 1996 The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and intiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3 J Biol Chem 271 17119 17123 8663332 10.1074/jbc.271.29.17124 1:CAS:528:DyaK28XksFams7w%3D (Pubitemid 26244262)
97. C Yan D Boyd 2007 Regulation of matrix metalloproteinase gene expression J Cell Physiol 211 19 26 17167774 10.1002/jcp.20948 1:CAS:528: DC%2BD2sXis12jt70%3D (Pubitemid 46363892)
98. Y Yoshihara H Nakamura K Obata, et al. 2000 Matrix metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis Ann Rheum Dis 59 455 461 10834863 10.1136/ard.59.6.455 1:CAS:528: DC%2BD3cXksVCktbw%3D (Pubitemid 30395603)
99. J Zwerina K Redlich K Polzer, et al. 2007 TNF-induced structural joint damage is mediated by interleukin-1 Proc Natl Acad Sci USA 104 11742 11747 17609389 10.1073/pnas.0610812104 1:CAS:528:DC%2BD2sXotVaksbk%3D (Pubitemid 47175083)